M. Tandia, “Bevacizumab and Sorafenib Modulate P-Glycoprotein Function In Vitro and Bevacizumab Increases In Vivo Sorafenib Plasma Concentrations in Mice”, ijirms, vol. 5, no. 08, pp. 261–267, Aug. 2020.